在偏头痛中使用抗CGRP单克隆抗体治疗期间延迟疹
Christoph T Berger1,2,3, Federico Burguet Villena3,4, Severin B Vogt5
1University Center for Immunology, University Hospital Basel, Basel, Switzerland.
Headache
|March 16, 2026
概括
与素基因相关 (CGRP) 向偏头痛预防的单克隆抗体 (mAbs) 相关的病通常是延迟和非IgE介导的. H1-抗组胺前期治疗可能允许继续使用这些有效的偏头痛治疗方法.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 素基因相关 (CGRP) 向单克隆抗体 (mAbs) 是有效的偏头痛预防药物.
- 过敏反应,包括疹,与向CGRP的mAbs.有关.
- 这些反应的机制,风险因素和管理尚不清楚.
研究的目的:
- 为了描述与CGRP向mAbs.相关的疹的临床表现.
- 评估CGRP向的mAbs.在接受CGRP向的mAbs.治疗的患者中疹的管理策略.
- 评估在疹反应后对CGRP向的mAbs进行再暴露的安全性和有效性.
主要方法:
- 五名患者的回顾性病例系列在CGRP向的mAb给药后出现了疹.
- 分析反应时间,病史,再暴露方案和临床结果.
- 查看图表以收集详细的患者信息.
主要成果:
- 在所有患者中,疹的发病时间都延迟了 (12-48小时),这表明非IgE介导的过敏.
- 五分之四的患者有疹病史.
- 在所有接受治疗的患者中,H1-抗组胺前期治疗使得成功的再暴露成为可能,而不管是否切换mAbs.
结论:
- 延迟,可能非IgE介导的疹与CGRP向的mAbs.相关.
- 个性化管理,包括H1-抗组胺前期治疗,可以促进持续的偏头痛预防.
- 需要进行更大规模的研究来确定风险因素和完善管理准则.
相关概念视频
Myasthenia Gravis: Overview and Treatment
3.3K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.3K
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions
127
Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
127
Cholinergic Antagonists: Therapeutic Uses
1.6K
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
1.6K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
723
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
723
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
2.2K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.2K
Hypersensitivity Reactions: Cytolytic Reactions
88
Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
88


